Document is current

Any future updates will be listed below

PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy

Crossref DOI link: https://doi.org/10.1038/s41418-024-01317-2

Published Online: 2024-05-30

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark